Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Reviral Ltd.
Headquarters: Stevenage, United Kingdom
Website: N/A
Year Founded: 2011
Status: Acquired
BioCentury | Oct 3, 2024
Management Tracks
New chairs for Progentos, Curve and Eligo
Plus: Nxera names BMS vet Sugita CMO, Japan president, and updates from Achieve, Every Cure and more
BioCentury | Nov 2, 2022
Product Development
Pfizer looking to RSV vaccine for fresh growth
Data in maternal setting set pharma up to seek approval this year
BioCentury | May 11, 2022
Deals
Pfizer’s Biohaven $11.6B takeout could fuel its spinout through the bear market
Pharma acquires leading position in the oral CGRP market through acquisition
BioCentury | Apr 7, 2022
Deals
VCs realize exit as Pfizer adds RSV therapy via ReViral takeout
Early investors including Andera, OrbiMed gain liquidity in deal worth up to $525M, giving Pfizer an antiviral for RSV
BioCentury | Jan 19, 2022
Management Tracks
Interim no more: Zhang assumes Overland’s CEO post; Maraganore, Ho join as advisers
Plus: Merck KGaA strategy, R&D execs; and updates from CureVac, Exo, Krystal and more
BioCentury | Jan 15, 2022
Management Tracks
Founder El-Hibri to retire from Emergent
Plus CEO Sandanayaka shifts to CSO at Nirogy, and updates from Angelini, Apie,
BioCentury | May 5, 2021
Finance
Europe’s top venture fund-raisers in 2018-20: Data Byte
At least six European biotechs raised more than $100 million in 2018-20 and are still private, with Oxford Nanopore Technologies Ltd. topping the list at $314.6 million. A further four companies
BioCentury | Mar 3, 2021
Deals
March 3 Quick Takes: Resilience acquires two manufacturing facilities in North America; plus Agilent-Resolution, AbbVie-Mitokinin, Fusion-Ipsen, LianBio-ReViral and Lava
National Resilience Inc. acquired two North American biopharma manufacturing facilities: a 310,000-square-foot biologics and advanced therapeutics Boston plant from Sanofi (Euronext:SAN; NASDAQ:SNY)
BioCentury | Aug 26, 2020
Deals
Aug. 25 Quick Takes: A slew of private financings led by Connect’s $115M series C; plus BMS-Forbius, Takeda deals, Bio-Thera-BeiGene and adds to HKSE, NASDAQ queues
Connect raises $115M C round, eyes pivotal trialsRA Capital’s Derek DiRocco will join the board of Suzhou Connect Biopharmaceuticals Ltd. after the firm led the Chinese biotech’s
BioCentury | Jun 11, 2019
Company News
Management Tracks: Agios’ Biller to retire as CSO; plus Vectura, Molecular Partners, F-star and more
Items per page:
1 - 10 of 21